Accuray (ARAY) EBIT Growth (3y) (2013 - 2026)
Accuray (ARAY) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 13.06% |
| 10 | Accuray | 35.97 Mn | -3.73 Mn | 25.29 Mn | -73.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.26% |
| Dec 31, 2025 | -84.45% |
| Sep 30, 2025 | -73.08% |
| Jun 30, 2025 | 6.68% |
| Mar 31, 2025 | -16.08% |
| Dec 31, 2024 | 5.74% |
| Sep 30, 2024 | -42.46% |
| Jun 30, 2024 | 27.50% |
| Mar 31, 2024 | -32.93% |
| Dec 31, 2023 | -35.42% |
| Sep 30, 2023 | -26.03% |
| Jun 30, 2023 | 3.61% |
| Mar 31, 2023 | -29.11% |
| Dec 31, 2022 | -9.28% |
| Sep 30, 2022 | 20.11% |
| Jun 30, 2022 | 12.15% |
| Mar 31, 2022 | 28.41% |
| Dec 31, 2021 | 87.45% |
| Sep 30, 2021 | 35.98% |
| Jun 30, 2021 | -8.88% |